The most recent AKI markers are tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor binding protein 7 (IGFBP7) which have been validated in the setting of cardiac and non-cardiac surgery [36,37]. Here, TIMP2 is linked to acute kidney injury.